233
Views
37
CrossRef citations to date
0
Altmetric
Multiple Myeloma

HLA-G expression in B chronic lymphocytic leukemia: a new prognostic marker?

, , , , &
Pages 101-105 | Published online: 18 Jul 2013

References

  • Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN, Pasternack BS. Clinical staging of chronic lymphocytic leukemia. Blood 1975; 46: 219–234.
  • Geraghty DE, Koller BH, Orr HT. A human major histocompat-ibility complex class I gene that encodes a protein with a shortened cytoplasmic segment. Proc Natl Acad Sci USA 1987; 84: 9145–9149.
  • Loke YW, Hiby S, King A. Human leucocyte antigen-G and reproduction. J Reprod Immunol 1999; 43: 235–242.
  • Blaschitz A, Lenfant F, Mallet V, Hartmann M, Bensussan A, Geraghty DE, Le Bouteiller P, Dohr G. Endothelial cells in chorionic fetal vessels of first trimester placenta express HLA-G. Eur J Immunol 1997; 27: 3380–3388.
  • Schust DJ, Tortorella D, Ploegh HL. HLA-G and HLA-C at the feto-maternal interface: lessons learned from pathogenic viruses. Semin Cancer Biol 1999; 9: 37–46.
  • King A, Burrows TD, Hiby SE, Bowen JM, Joseph S, Verma S, Lim PB, Gardner L, Le Bouteiller P, Ziegler A, Uchanska-Ziegler B, Loke YW. Surface expression of HLA-C antigen by human extravillous trophoblast. Placenta 2000; 21: 376–387.
  • O'Callaghan CA, Bell JI. Structure and function of the human MHC class Ib molecules HLA-E, HLA-F and HLA-G. Immunol Rev 1998; 163: 129–138.
  • Cabestre FA, Lefebvre S, Moreau P, Rouas-Friess N, Dausset J, Carosella ED, Paul P. HLA-G expression: immune privilege for tumour cells? Semin Cancer Biol 1999; 9: 27–36.
  • Wagner SN, Rebmann V, Willers CP, Grosse-Wilde H, Goos M. Expression analysis of classic and non-classic HLA molecules before interferon alfa-2b Treatment of melanoma. Lancet 2000; 356: 220–221.
  • Wiendl H, Mitsdoerffer M, Hofmeister V, Wischhusen J, Bornemann A, Meyermann R, Weiss EH, Melms A, Weller M. A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape. J Immunol 2002; 68: 4772–4780.
  • Damle RN, Wasil T, Fais F, Ghiotto F, Valetto A, Allen SL, Buchbinder A, Budman D, Dittmar K, Kolitz J, Lichtman SM, Schulman P, Vinciguerra VP, Rai KR, Ferrarini M, Chiorazzi N. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999; 94: 1840–1847.
  • Titus K. Zigs and Zags on the ZAP-70 Highway. College of American Pathologists, 2004; www.cap.org.
  • Rebmann V, Pfeiffer K, Passler M, Ferrone S, Maier S, Weiss E, Grosse-Wilde H. Detection of soluble HLA-G molecules in plasma and amniotic fluid. Tissue Antigens 1999; 53: 14–22.
  • Schmidt CM, Orr HT. Maternal/fetal Interactions: the role of the MHC class I molecule HLA-G. Crit Rev Immunol 1993; 3: 207–224.
  • Paul P, Rouas-Freiss N, Khalil-Daher I, Moreau P, Riteau B, Le Gal FA, Avril MF, Dausset J, Guillet JG, Carosella ED. HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance. Proc Natl Acad Sci USA 1998; 95:4510–4515.
  • Pangault C, Amiot L, Caulet-Maugendre S, Brasseur F, Burtin F, Guilloux V, Drenou B, Fauchet R, Onno M. HLA-G protein expression is not induced during malignant transformation. Tissue Antigens 1999; 53: 335–346.
  • Moreau P, Adrian-Cabestre F, Menier C, Guiard V, Gourand L, Dausset J, Carosella ED, Paul P. IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes. Int Immunol 1999; 11: 803–811.
  • Chang CC, Ferrone S. HLA-G in melanoma: can the current controversies be solved? Semin Cancer Biol 2003; 13: 361–369.
  • Del Prete G, de Carli M, Almerigogna F, Giudizi MG, Biagiotti R, Romagnani S. Human IL-10 is produced by both type 1 helper (Thl) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J Immunol 1993; 150: 353–360.
  • O'Garra A, Stapleton G, Dhar V, Pearce M, Schumacher J, Rugo H, Barbis D, Stall A, Cupp J, Moore K, et al. Production of cytokines by mouse B cells: B lymphomas and normal B cells produce interleukin 10. Int Immunol 1990; 2: 821–832.
  • Yssel H, de Waal Malefyt R, Roncarolo MG, Abrams is, Lahesmaa R, Spits H, de Vries JE. IL-10 is Produced by subsets of human CD4+ T cell clones and peripheral blood t cells. J Immunol 1992; 149: 2378–2384.
  • Mizuno S, Emi N, Kasai M, Ishitani A, Saito H. Aberrant expression of HLA-G antigen in interferon gamma-stimulated acute myelogenous leukaemia. Br J Haematol 2000; 111: 280–282.
  • Polakova K, Krcova M, Kuba D, Russ G. Analysis of HLA-G expression in malignant hematopoetic cells from leukemia patients. Leukemia Research 2003; 50: 331–338.
  • Niickel H, Rebmann V, Diirig J, Diihrsen U, Grosse-Wilde H. HLA-G expression is associated with an unfavorable outcome and immunodeficiency in chronic lymphocytic leukemia. Blood 2005; 105: 1694–1698.
  • Dummer R, Willers J, Kamarashev J, Urosevic M, Döbbeling U, Burg G. Pathogenesis of cutaneous lymphomas. Semin Cutan Med Surg 2000; 19: 78–86.
  • Asadullah K, Dikke WD, Volk HD, Sterry W. Cytokines and cutaneous T-cell lymphomas. Exp Dermatol 1998; 7: 314–20.
  • Maki G, Hayes GM, Naji A, Tyler T, Carosella ED, Rouas-Freiss N, Gregory SA. NK resistance of tumor cells from multiple myeloma and chronic lymphocytic leukemia patients: implication of HLA-G. Leukemia 2008; 22: 998–1006.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.